Bone Biologics (BBLG) Total Current Liabilities (2016 - 2017)

Historic Total Current Liabilities for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $3.8 million.

  • Bone Biologics' Total Current Liabilities rose 103806.81% to $3.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $3.8 million, marking a year-over-year increase of 103806.81%. This contributed to the annual value of $1.5 million for FY2016, which is N/A changed from last year.
  • Per Bone Biologics' latest filing, its Total Current Liabilities stood at $3.8 million for Q3 2017, which was up 103806.81% from $2.7 million recorded in Q2 2017.
  • Bone Biologics' 5-year Total Current Liabilities high stood at $3.8 million for Q3 2017, and its period low was $335622.0 during Q3 2016.